REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 75 filers reported holding REPARE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,058,190 | +28.4% | 3,067,731 | +12.5% | 1.43% | +7.0% |
| Q2 2023 | $28,858,071 | +7.5% | 2,727,606 | 0.0% | 1.34% | +21.2% |
| Q1 2023 | $26,839,643 | -33.1% | 2,727,606 | 0.0% | 1.10% | -34.6% |
| Q4 2022 | $40,123,084 | +5.8% | 2,727,606 | -12.8% | 1.68% | -3.0% |
| Q3 2022 | $37,939,000 | +0.2% | 3,127,667 | +15.5% | 1.74% | -30.2% |
| Q2 2022 | $37,880,000 | -0.1% | 2,707,662 | +1.6% | 2.49% | +2.3% |
| Q1 2022 | $37,936,000 | -14.3% | 2,664,017 | +26.9% | 2.43% | -22.2% |
| Q4 2021 | $44,289,000 | – | 2,100,000 | – | 3.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,242,636 | $32,989,176 | 13.80% |
| CHI Advisors LLC | 2,800,126 | $41,189,854 | 10.97% |
| MPM BioImpact LLC | 1,639,849 | $24,122,179 | 6.26% |
| BVF INC/IL | 8,291,988 | $121,975,143 | 5.15% |
| Deep Track Capital, LP | 2,727,606 | $40,123,084 | 1.68% |
| Redmile Group, LLC | 2,684,396 | $39,487,465 | 1.62% |
| HighVista Strategies LLC | 164,890 | $2,425,532 | 1.44% |
| Orbimed Advisors | 3,322,488 | $48,873,798 | 0.94% |
| Artal Group S.A. | 700,000 | $10,297 | 0.58% |
| HARBOR CAPITAL ADVISORS, INC. | 34,572 | $508,554 | 0.49% |